PSA · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $4.82B | $4.70B | $4.52B | $4.18B | $3.42B | $2.92B | $2.86B | $2.76B |
| Cost of Revenue | — | — | — | — | — | — | — | $739.72M |
| Gross Profit | — | — | — | — | — | — | — | $2.01B |
| Selling, General & Administrative | $106.68M | $106.68M | $80.63M | $71.67M | $75.97M | $83.20M | $62.15M | $104.71M |
| Operating Expenses | $2.89B | $2.80B | $2.43B | $2.18B | $1.81B | $1.56B | $1.43B | $1.38B |
| Interest Expense | $304.50M | $287.40M | $201.13M | $136.32M | $90.77M | $56.28M | $45.64M | $32.54M |
| Income Before Taxes | $1.79B | $2.09B | $2.17B | $4.38B | $1.97B | — | — | — |
| Provision for Income Taxes | -$7.23M | $4.67M | $10.82M | $14.33M | $12.37M | — | — | — |
| Net Income | $1.78B | $2.07B | $2.15B | $4.35B | $1.95B | $1.36B | $1.52B | $1.71B |
| Basic EPS | $9.04 | $10.68 | $11.11 | $23.64 | $9.91 | $6.29 | $7.30 | $8.56 |
| Diluted EPS | $9.01 | $10.64 | $11.06 | $23.50 | $9.87 | $6.29 | $7.29 | $8.54 |
| Basic Shares Outstanding | 175.45M | 175.35M | 175.47M | 175.26M | 174.86M | 174.49M | 174.29M | 173.97M |
| Diluted Shares Outstanding | 175.90M | 176.04M | 176.14M | 176.28M | 175.57M | 174.64M | 174.53M | 174.30M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $16.93 | $16.85 | $17.04 | 8 | ↑0 ↓1 |
| Dec 2027 | $17.42 | $17.10 | $17.76 | 8 | ↑1 ↓1 |
| Dec 2028 | $17.91 | $17.89 | $17.92 | 2 | ↑0 ↓0 |